{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:22:24Z","timestamp":1783725744018,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medlior Health Outcomes Research"}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cjca.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T23:59:39Z","timestamp":1562543979000},"page":"884-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta"],"prefix":"10.1016","volume":"35","author":[{"given":"Guanmin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Pericleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raina M.","family":"Rogoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.04.008_bib1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib2","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.cjca.2016.11.009","article-title":"Recent temporal changes in atherosclerotic cardiovascular diseases in Ontario: clinical and health systems impact","volume":"33","author":"Tu","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib4","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.04.008_bib5","series-title":"Health Fact Sheets: The 10 Leading Causes of Death, 2013","author":"Statistics Canada","year":"2017"},{"key":"10.1016\/j.cjca.2019.04.008_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1503\/cmaj.131358","article-title":"The CANHEART health index: a tool for monitoring the cardiovascular health of the Canadian population","volume":"186","author":"Maclagan","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2019.04.008_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/03007995.2017.1401529","article-title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","volume":"34","author":"Cherepanov","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cjca.2019.04.008_bib8","series-title":"The Economic Burden of Illness in Canada, 2010","year":"2017"},{"key":"10.1016\/j.cjca.2019.04.008_bib9","series-title":"Population health impact of statin treatment in Canada","author":"Hennessy","year":"2016"},{"key":"10.1016\/j.cjca.2019.04.008_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cjca.2016.07.005","article-title":"Cardiovascular risk factor management performance in Canada and the United States: a systematic review","volume":"33","author":"Alabousi","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib11","first-page":"e495","article-title":"Statin-prescribing trends for primary and secondary prevention of cardiovascular disease","volume":"63","author":"Brown","year":"2017","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.cjca.2019.04.008_bib12","series-title":"ICD-9-CM Diagnosis and Procedure Codes: Abbreviated and Full Code Titles. Vol 20","year":"2014"},{"key":"10.1016\/j.cjca.2019.04.008_bib13","series-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada (ICD-10-CA), Volume \u2014Tabular List","year":"2012"},{"key":"10.1016\/j.cjca.2019.04.008_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjca.2019.04.008_bib15","series-title":"Using arrays to calculate medication utilization. Proceedings of the 2007 SAS Global Forum","author":"Leslie","year":"2007"},{"key":"10.1016\/j.cjca.2019.04.008_bib16","first-page":"892","article-title":"Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC\/AHA guideline on the treatment of blood cholesterol","volume":"22","author":"Bellows","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.cjca.2019.04.008_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10557-018-6810-1","article-title":"Trends in statin use 2009\u20132015 in a large integrated health system: pre-and post-2013 ACC\/AHA guideline on treatment of blood cholesterol","volume":"32","author":"Harrison","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cjca.2019.04.008_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2796.1997.112133000.x","article-title":"The problem of compliance to cholesterol altering therapy","volume":"241","author":"Insull","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2019.04.008_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187809","article-title":"An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System","volume":"12","author":"Lucas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2019.04.008_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cjca.2019.04.008_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0895-4356(01)00521-2","article-title":"Measuring potentially avoidable hospital readmissions","volume":"55","author":"Halfon","year":"2002","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cjca.2019.04.008_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2019.04.008_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","article-title":"Predictors of adherence with antihypertensive and lipid-lowering therapy","volume":"165","author":"Chapman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2019.04.008_bib26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00002512-200825100-00008","article-title":"Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults","volume":"25","author":"Chapman","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.cjca.2019.04.008_bib27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cjca.2017.02.005","article-title":"Statin prescriptions for high-risk patients are increased by laboratory-initiated Framingham Risk Scores: a quality-improvement initiative","volume":"33","author":"Naugler","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.04.008_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11883-017-0683-9","article-title":"Statin prescribing in the elderly: special considerations","volume":"19","author":"Leya","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cjca.2019.04.008_bib29","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.04.008_bib30","first-page":"555","article-title":"Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context","volume":"20","author":"Toth","year":"2017","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.cjca.2019.04.008_bib31","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"Trialists","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.04.008_bib32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.04.008_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2261-12-74","article-title":"Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention-a cross sectional study","volume":"12","author":"Liddy","year":"2012","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19302697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19302697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T09:55:28Z","timestamp":1610272528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19302697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0828282X19302697"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.04.008","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}